Pascal Rihet

Dr. Pascal Rihet

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2011 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
NDNicolas F Delahaye
Nicolas F Delahaye
SRSylvie Rusakiewicz
Sylvie Rusakiewicz
IMIsabelle Martins
Isabelle Martins
CMCédric Ménard
Cédric Ménard
SRStephan Roux
Stephan Roux
LZLaurence Zitvogel
Laurence Zitvogel

1 November 1991 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PRPascal Rihet
Pascal Rihet
CDChristian E. Demeure
Christian E. Demeure
ABAlain Bourgois
Alain Bourgois
APAluizio Prata
Aluizio Prata
ADAlain J. Dessein
Alain J. Dessein

1 March 2000 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
CAChristophe Aucan
Christophe Aucan
YTYves Traoré
Yves Traoré
FTFrançois Tall
François Tall
BNBoubacar Nacro
Boubacar Nacro
TTThérèse Traoré-Leroux
Thérèse Traoré-Leroux
PRPascal Rihet
Pascal Rihet
There is accumulating evidence for a role of immunoglobulin G (IgG) in protection against malarial infection and disease. Only IgG1 and IgG3 are considered cytophilic and protective againstP. falciparum, whereas IgG2 and IgG4 were thought to be neither and even to block protective mechanisms. However, no clear pattern of association between isotypes and protection has so far emerged. We analyzed the isotypic distribution of the IgG response to conserved epitopes andP. falciparumblood-stage extract in 283 malaria-exposed individuals whose occurrence of infection and malaria attack had been monitored for about 1 year. Logistic regression analyses showed that, at the end of the season of transmission, high levels of IgG2 to RESA and to MSP2 epitopes were associated with low risk of infection. Indeed, IgG2 is able to bind FcγRIIA in individuals possessing the H131 allele, and we showed that 70% of the study subjects had this allele. Also, high specific IgG4 levels were associated with an enhanced risk of infection and with a high risk of malaria attack. Moreover, specific IgG2 and IgG3 levels, as well as the IgG2/IgG4 and IgG3/IgG4 ratios, increased with the age of subjects, in parallel with the protection against infection and disease. IgG4 likely competes with cytophilic antibodies for antigen recognition and may therefore block cytotoxicity mediated by antibody-activated effector cells. In conclusion, these results favor a protective role of IgG3 and IgG2, which may activate effector cells through FcγRIIA, and provide evidence for a blocking role of IgG4 in malarial infection and disease.

1 October 1993 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
CDC. E. Demeure
C. E. Demeure
PRPascal Rihet
Pascal Rihet
LAL. Abel
L. Abel
MOM. Ouattara
M. Ouattara
ABA. Bourgois
A. Bourgois
ADA. J. Dessein
A. J. Dessein
The hypothesis of an association between human resistance to reinfection by the parasite Schistosoma mansoni and anti-larval immunoglobulin isotypes was tested by logistic regression in the presence of the explicative variables water contact, age, and sex. Of the seven isotypes tested (IgM, IgGl, IgG2, IgG3, IgG4, IgA, and IgE), only IgE, IgG4, and IgG2 showed an association (positive for IgE and negative for IgG2 and IgG4) with resistance to reinfection after chemotherapy. The opposite effects of IgE and IgG4 were undissociable in the analysis, indicating that these isotypes probably antagonize each other in protection. The negative association of IgG2 with resistance is consistent with the view that anti-carbohydrate antibodies may facilitate reinfection. Finally, epidemiologic and immunologic studies support the view that there is a progressive but slow development of acquired immunity in children and adolescents.

1 August 1998 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PRPascal Rihet
Pascal Rihet
YTYves Traoré
Yves Traoré
LALaurent Abel
Laurent Abel
CAChristophe Aucan
Christophe Aucan
TTThérèse Traoré-Leroux
Thérèse Traoré-Leroux
FFFrancis Fumoux
Francis Fumoux

20 July 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SDStéphanie Devignot
Stéphanie Devignot
CSCédric Sapet
Cédric Sapet
VDVeasna Duong
Veasna Duong
ABAurélie Bergon
Aurélie Bergon
PRPascal Rihet
Pascal Rihet
PCPatricia Couissinier-Paris
Patricia Couissinier-Paris
Deciphering host responses contributing to dengue shock syndrome (DSS), the life-threatening form of acute viral dengue infections, is required to improve both the differential prognosis and the treatments provided to DSS patients, a challenge for clinicians. Based on a prospective study, we analyzed the genome-wide expression profiles of whole blood cells from 48 matched Cambodian children: 19 progressed to DSS while 16 and 13 presented respectively classical dengue fever (DF) or dengue hemorrhagic fever grades I/II (DHF). Using multi-way analysis of variance (ANOVA) and adjustment of p-values to control the False Discovery Rate (FDR<10%), we identified a signature of 2959 genes differentiating DSS patients from both DF and DHF, and showed a strong association of this DSS-gene signature with the dengue disease phenotype. Using a combined approach to analyse the molecular patterns associated with the DSS-gene signature, we provide an integrative overview of the transcriptional responses altered in DSS children. In particular, we show that the transcriptome of DSS children blood cells is characterized by a decreased abundance of transcripts related to T and NK lymphocyte responses and by an increased abundance of anti-inflammatory and repair/remodeling transcripts. We also show that unexpected pro-inflammatory gene patterns at the interface between innate immunity, inflammation and host lipid metabolism, known to play pathogenic roles in acute and chronic inflammatory diseases associated with systemic vascular dysfunction, are transcriptionnally active in the blood cells of DSS children. We provide a global while non exhaustive overview of the molecular mechanisms altered in of DSS children and suggest how they may interact to lead to final vascular homeostasis breakdown. We suggest that some mechanisms identified should be considered putative therapeutic targets or biomarkers of progression to DSS.